Waverly Advisors’s RxSight RXST Stock Holding History

Waverly Advisors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,659	Closed	-$217K	–	1316
2025 Q2	$217K	Buy	16,659 +41	+0.2%	+$616	﹤0.01%	1089
2025 Q1	$420K	Buy	+16,618	New	+$494K	0.01%	825

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Waverly Advisors's RXST Position: Q3 2025 in Review

Waverly Advisors sold out of RxSight (RXST) in Q3 2025, closing a stake of 16,659 shares — an estimated $217K sold.

Waverly Advisors first reported a position in RXST in Q1 2025 and held it in 2 quarters. The position peaked at $420K in Q1 2025. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

Waverly Advisors reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
Waverly Advisors sold 16,659 RxSight shares in Q3 2025, an estimated $217K.
Waverly Advisors first reported a position in RxSight in Q1 2025 and held it in 2 quarters.
Waverly Advisors's RxSight position peaked at $420K in Q1 2025.
160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Waverly Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.